A bone conduction implant using self-drilling screws : Self-drilling screws as a new fixation method of an active transcutaneous bone conduction hearing implant.

Knochenleitungsimplantat mit selbstbohrenden Schrauben : Neue Methode der Fixation eines aktiven transkutanen Knochenleitungshörimplantats.

Journal

HNO
ISSN: 1433-0458
Titre abrégé: HNO
Pays: Germany
ID NLM: 2985099R

Informations de publication

Date de publication:
Aug 2023
Historique:
accepted: 06 04 2023
medline: 9 8 2023
pubmed: 16 6 2023
entrez: 15 6 2023
Statut: ppublish

Résumé

The active transcutaneous bone conduction implant (tBCI; BONEBRIDGE™ BCI 601; MED-EL, Innsbruck, Austria) is fixed to the skull with two self-tapping screws in predrilled screw channels. The aim of this prospective study was to evaluate the safety and effectiveness of fixation with self-drilling screws instead of the self-tapping screws, in order to simplify the surgical procedure. Nine patients (mean age 37 ± 16 years, range 14-57 years) were examined pre- and 12 months postoperatively for word recognition scores (WRS) at 65 dB SPL, sound-field (SF) thresholds, bone conduction thresholds (BC), health-related quality of life (Assessment of Quality of Life, AQOL-8D questionnaire), and adverse events (AE). Due to avoidance of one surgical step, the surgical technique was simplified. Mean WRS in SF was 11.1 ± 22.2% (range 0-55%) pre- and 77.2 ± 19.9% (range 30-95%) postoperatively; mean SF threshold (pure tone audiometry, PTA Implant fixation by means of self-drilling screws was safe and effective in all nine patients. There was significant audiological benefit 12 months after implantation.

Sections du résumé

BACKGROUND BACKGROUND
The active transcutaneous bone conduction implant (tBCI; BONEBRIDGE™ BCI 601; MED-EL, Innsbruck, Austria) is fixed to the skull with two self-tapping screws in predrilled screw channels. The aim of this prospective study was to evaluate the safety and effectiveness of fixation with self-drilling screws instead of the self-tapping screws, in order to simplify the surgical procedure.
MATERIALS AND METHODS METHODS
Nine patients (mean age 37 ± 16 years, range 14-57 years) were examined pre- and 12 months postoperatively for word recognition scores (WRS) at 65 dB SPL, sound-field (SF) thresholds, bone conduction thresholds (BC), health-related quality of life (Assessment of Quality of Life, AQOL-8D questionnaire), and adverse events (AE).
RESULTS RESULTS
Due to avoidance of one surgical step, the surgical technique was simplified. Mean WRS in SF was 11.1 ± 22.2% (range 0-55%) pre- and 77.2 ± 19.9% (range 30-95%) postoperatively; mean SF threshold (pure tone audiometry, PTA
CONCLUSION CONCLUSIONS
Implant fixation by means of self-drilling screws was safe and effective in all nine patients. There was significant audiological benefit 12 months after implantation.

Identifiants

pubmed: 37322168
doi: 10.1007/s00106-023-01295-w
pii: 10.1007/s00106-023-01295-w
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

61-66

Informations de copyright

© 2023. The Author(s), under exclusive licence to Springer Medizin Verlag GmbH, ein Teil von Springer Nature.

Références

Baumgartner WD, Hamzavi JS, Boheim K, Wolf-Magele A, Schlogel M, Riechelmann H (2016) A new transcutaneous bone conduction hearing implant. Otol Neurotol 37(6):713–720. https://doi.org/10.1097/MAO.0000000000001038
doi: 10.1097/MAO.0000000000001038 pubmed: 27153327
Bravo-Torres S, Der-Mussa C, Fuentes-Lopez E (2018) Active transcutaneous bone conduction implant: audiological results in paediatric patients with bilateral microtia associated with external auditory canal atresia. Int J Audiol 57(1):53–60. https://doi.org/10.1080/14992027.2017.1370137
doi: 10.1080/14992027.2017.1370137 pubmed: 28857620
Brkic FF, Riss D, Arnoldner C, Liepins R, Gstöttner W, Baumgartner WD, Vyskocil E (2021) Safety and efficacy of implantation of the bonebridge active transcutaneous bone-conduction device using implant lifts. J Am Acad Audiol 32(5):290–294. https://doi.org/10.1055/s-0041-1723038
doi: 10.1055/s-0041-1723038 pubmed: 34062601
Brkic FF, Riss D, Scheuba K, Arnoldner C, Gstottner W, Baumgartner WD, Vyskocil E (2019) Medical, technical and audiological outcomes of hearing rehabilitation with the bonebridge transcutaneous bone-conduction implant: a single-center experience. J Clin Med 8(10):1614. https://doi.org/10.3390/jcm8101614
doi: 10.3390/jcm8101614 pubmed: 31623414 pmcid: 6832994
Canale A, Boggio V, Albera A, Ravera M, Caranzano F, Lacilla M, Albera R (2019) A new bone conduction hearing aid to predict hearing outcome with an active implanted device. Eur Arch Otorhinolaryngol 276(8):2165–2170. https://doi.org/10.1007/s00405-019-05450-4
doi: 10.1007/s00405-019-05450-4 pubmed: 31053966
Carnevale C, Til-Perez G, Arancibia-Tagle DJ, Tomas-Barberan MD, Sarria-Echegaray PL (2019) Hearing outcomes of the active bone conduction system Bonebridge((R)) in conductive or mixed hearing loss. Acta Otorrinolaringol Esp 70(2):80–88. https://doi.org/10.1016/j.otorri.2018.02.006
doi: 10.1016/j.otorri.2018.02.006
Cywka KB, Skarzynski PH, Krol B, Hatzopoulos S, Skarzynski H (2022) Evaluation of the Bonebridge BCI 602 active bone conductive implant in adults: efficacy and stability of audiological, surgical, and functional outcomes. Eur Arch Otorhinolaryngol 279(7):3525–3534. https://doi.org/10.1007/s00405-022-07265-2
doi: 10.1007/s00405-022-07265-2 pubmed: 35182185 pmcid: 9130189
Hawthorne G, Osborne R (2005) Population norms and meaningful differences for the Assessment of Quality of Life (AQoL) measure. Aust N Z J Public Health 29(2):136–142. https://doi.org/10.1111/j.1467-842x.2005.tb00063.x
doi: 10.1111/j.1467-842x.2005.tb00063.x pubmed: 15915617
Ihler F, Blum J, Berger MU, Weiss BG, Welz C, Canis M (2016) The prediction of speech recognition in noise with a semi-implantable bone conduction hearing system by external bone conduction stimulation with headband: a prospective study. Trends Hear. https://doi.org/10.1177/2331216516669330
doi: 10.1177/2331216516669330 pubmed: 27698259 pmcid: 5051673
Maxwell A, Özmen M, Iezzi A, Richardson J (2016) Deriving population norms for the AQoL-6D and AQoL-8D multi-attribute utility instruments from web-based data. Qual Life Res 25(12):3209–3219. https://doi.org/10.1007/s11136-016-1337-z
doi: 10.1007/s11136-016-1337-z pubmed: 27344318
Papageorgiou SN, Zogakis IP, Papadopoulos MA (2012) Failure rates and associated risk factors of orthodontic miniscrew implants: a meta-analysis. Am J Orthod Dentofacial Orthop 142(5):577–595. https://doi.org/10.1016/j.ajodo.2012.05.016
doi: 10.1016/j.ajodo.2012.05.016 pubmed: 23116500
Rahne T, Seiwerth I, Gotze G, Heider C, Radetzki F, Herzog M, Plontke SK (2015) Functional results after Bonebridge implantation in adults and children with conductive and mixed hearing loss. Eur Arch Otorhinolaryngol 272(11):3263–3269. https://doi.org/10.1007/s00405-014-3403-x
doi: 10.1007/s00405-014-3403-x pubmed: 25425039
Riss D, Arnoldner C, Baumgartner WD, Blineder M, Flak S, Bachner A et al (2014) Indication criteria and outcomes with the bonebridge transcutaneous bone-conduction implant. Laryngoscope 124(12):2802–2806. https://doi.org/10.1002/lary.24832
doi: 10.1002/lary.24832 pubmed: 25142577
Siegel L, You P, Zimmerman K, Parnes L, Agrawal SK (2020) Active transcutaneous bone conduction implant: audiometric outcomes following a novel middle fossa approach with self-drilling screws. Otol Neurotol 41(5):605–613. https://doi.org/10.1097/MAO.0000000000002597
doi: 10.1097/MAO.0000000000002597 pubmed: 32080031
Skarzynski PH, Krol B, Skarzynski H, Cywka KB (2022) Implantation of two generations of bonebridge after mastoid obliteration with bioactive glass S53P4. Am J Otolaryngol 43(5):103601. https://doi.org/10.1016/j.amjoto.2022.103601
doi: 10.1016/j.amjoto.2022.103601 pubmed: 35981433
Sprinzl G, Lenarz T, Ernst A, Hagen R, Wolf-Magele A, Mojallal H et al (2013) First European multicenter results with a new transcutaneous bone conduction hearing implant system: short-term safety and efficacy. Otol Neurotol 34(6):1076–1083. https://doi.org/10.1097/MAO.0b013e31828bb541
doi: 10.1097/MAO.0b013e31828bb541 pubmed: 23714710
Sprinzl G, Lenarz T, Hagen R, Baumgartner WD, Keintzel T, Keck T et al (2021) Long-term, multicenter results with the first transcutaneous bone conduction implant. Otol Neurotol 42(6):858–866. https://doi.org/10.1097/MAO.0000000000003159
doi: 10.1097/MAO.0000000000003159 pubmed: 33989254
Sprinzl G, Toner J, Koitschev A, Berger N, Keintzel T, Rasse T et al (2023) Multicentric study on surgical information and early safety and performance results with the Bonebridge BCI 602: an active transcutaneous bone conduction hearing implant. Eur Arch Otorhinolaryngol. https://doi.org/10.1007/s00405-022-07792-y
doi: 10.1007/s00405-022-07792-y pubmed: 36625869 pmcid: 9988757
Vyskocil E, Riss D, Arnoldner C, Hamzavi JS, Liepins R, Kaider A et al (2017) Dura and sinus compression with a transcutaneous bone conduction device—hearing outcomes and safety in 38 patients. Clin Otolaryngol 42(5):1033–1038. https://doi.org/10.1111/coa.12793
doi: 10.1111/coa.12793 pubmed: 27860393
Weiss R, Leinung M, Baumann U, Weissgerber T, Rader T, Stover T (2017) Improvement of speech perception in quiet and in noise without decreasing localization abilities with the bone conduction device bonebridge. Eur Arch Otorhinolaryngol 274(5):2107–2115. https://doi.org/10.1007/s00405-016-4434-2
doi: 10.1007/s00405-016-4434-2 pubmed: 28032241
Yi J, Ge M, Li M, Li C, Li Y, Li X, Zhao Z (2017) Comparison of the success rate between self-drilling and self-tapping miniscrews: a systematic review and meta-analysis. Eur J Orthod 39(3):287–293. https://doi.org/10.1093/ejo/cjw036
doi: 10.1093/ejo/cjw036 pubmed: 27166073
You P, Siegel LH, Kassam Z, Hebb M, Parnes L, Ladak HM, Agrawal SK (2019) The middle fossa approach with self-drilling screws: a novel technique for BONEBRIDGE implantation. J Otolaryngol Head Neck Surg 48(1):35. https://doi.org/10.1186/s40463-019-0354-7
doi: 10.1186/s40463-019-0354-7 pubmed: 31358057 pmcid: 6664741
Zernotti ME, Chiaraviglio MM, Mauricio SB, Tabernero PA, Zernotti M, Di Gregorio MF (2019) Audiological outcomes in patients with congenital aural atresia implanted with transcutaneous active bone conduction hearing implant. Int J Pediatr Otorhinolaryngol 119:54–58. https://doi.org/10.1016/j.ijporl.2019.01.016
doi: 10.1016/j.ijporl.2019.01.016 pubmed: 30665177

Auteurs

Assen Koitschev (A)

Klinik für Hals‑, Nasen‑, Ohrenkrankheiten, Plastische Operationen, Klinikum Stuttgart-Olgahospital, Kriegsbergstraße 62, 70174, Stuttgart, Germany. a.koitschev@klinikum-stuttgart.de.

Marcus Neudert (M)

Klinik für Hals‑, Nasen‑, Ohrenkrankheiten, Plastische Operationen, Universitätsklinikum Carl Gustav Carus an der TU Dresden, Dresden, Germany.

Thomas Lenarz (T)

Klinik für Hals‑, Nasen‑, Ohrenkrankheiten, Plastische Operationen, Medizinische Hochschule Hannover, Hannover, Germany.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH